(WNDU) - Over 800,000 people are diagnosed with liver cancer every year worldwide. And it accounts for more than 700,000 ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit ...

By Dr. Joseph Kim University of Kentucky Liver cancer is the sixth leading cause cancer death in the U.S. The most common ...

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell ...

https://gco.iarc.who.int/media/globocan/factsheets/populations/356-india-fact-sheet.pdf ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term ...

Hepatic artery infusion delivers chemo directly into the liver, and that increases the survival rate by up to 40 percent.